Please ensure Javascript is enabled for purposes of website accessibility
Home > Products > Antibodies > Primary antibodies

Anti-PIM1 Polyclonal Antibody (HY563014)

Anti-PIM1 Polyclonal Antibody
Anti-PIM1 Polyclonal Antibody
Price(USD):
Spec:
  • 50ug
  • 100ug
Number:
Get quote
  • Overview

  • Images

  • References

  • Datasheet

  • SDS

Overview
Catalog No.HY563014
Description
Anti-PIM1 Polyclonal Antibody (HY563014) is a rabbit polyclonal antibody detecting PIM1 in ELISA, IHC, WB. Suitable for Bovine, Cat, Human, Mouse, and Rat.
Highlights
  • Affinity Purified — Minimal background and high purity for reliable results.
  • Multi-Application — Validated across multiple applications.
  • Multi-Species — Cross-reactive for translational research.
Species reactivityHuman, Mouse, Rat
ApplicationsELISA, IHC, WB
Host speciesRabbit
IsotypeIgG
Clonality Polyclonal
Immunogen E. coli - derived recombinant Human PIM1 (Ser98-Lys313).
Target PIM1, Serine/threonine-protein kinase pim-1
Purification Purified by antigen affinity column.
Accession P11309
Form Liquid
Storage buffer 0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

Product Usage Information
Application Dilution
ELISA 1:5000-1:20000
IHC 1:50-1:500
WB 1:500-1:2000
Stability and Storage Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Background

Serine/threonine-protein kinase pim-1 (PIM1) is a ~35 kDa protein. Proto-oncogene with serine/threonine kinase activity involved in cell survival and cell proliferation and thus providing a selective advantage in tumorigenesis. Exerts its oncogenic activity through: the regulation of MYC transcriptional activity, the regulation of cell cycle progression and by phosphorylation and inhibition of proapoptotic proteins (BAD, MAP3K5, FOXO3). Phosphorylation of MYC leads to an increase of MYC protein stability and thereby an increase of transcriptional activity. The stabilization of MYC exerted by PIM1 might explain partly the strong synergism between these two oncogenes in tumorigenesis. Mediates survival signaling through phosphorylation of BAD, which induces release of the anti-apoptotic protein Bcl-X(L)/BCL2L1.

1. Stout, BA. et al. (2004) Journal of immunology (Baltimore, Md. : 1950) 173, 6409-17. PMID: 15528381
2. Saris, CJ. et al. (1991) The EMBO journal 10, 655-64. PMID: 1825810
3. Padi, SKR. et al. (2019) Proceedings of the National Academy of Sciences of the United States of America 116, 20505-20510. PMID: 31548394
4. Morishita, D. et al. (2008) Cancer research 68, 5076-85. PMID: 18593906
5. Gu, JJ. et al. (2009) Oncogene 28, 4261-71. PMID: 19749799
6. Bachmann, M. et al. (2006) The international journal of biochemistry & cell biology 38, 430-43. PMID: 16356754
7. Wang, Z. et al. (2002) Biochimica et biophysica acta 1593, 45-55. PMID: 12431783
8. Koike, N. et al. (2000) FEBS letters 467, 17-21. PMID: 10664448
9. Fisch, D. et al. (2023) Science (New York, N.Y.) 382, eadg2253. PMID: 37797010
Note For research use only.
Images
  • Anti-PIM1 Polyclonal Antibody

    Western blot

    Western blot analysis was performed using anti-PIM1 polyclonal antibody at 1ug/mL on recombinant PIM1 (Catalog No. HY563012).

References
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recommendation

Contact us for custom quotes, bulk requests and any other issues.

Mail: support@abinScience.com

Distributor list